SynthesisFrontiers in neuroscience2026
Maternal vitamin B12, vitamin D, and folic acid status during pregnancy and child neurodevelopment: a systematic review.
Synthesis in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adequate maternal micronutrient status during pregnancy may play an important role in fetal neurodevelopment. Emerging evidence suggests that deficiencies in vitamin B12, vitamin D, and folic acid, often exacerbated by modern dietary patterns characterized by high consumption of ultra-processed foods, may adversely affect cognitive, motor, and behavioral outcomes in offspring. Despite growing interest in this topic, the magnitude and consistency of these associations remain incompletely defined. Methods: We conducted a systematic review in accordance with PRISMA 2020 guidelines. Electronic databases (PubMed, Cochrane Library, LILACS, and ScienceDirect) were searched for studies published up to March 2025 that evaluated maternal vitamin B12, vitamin D, or folate status during pregnancy and subsequent neurodevelopmental outcomes in children. Eligible studies included observational studies and randomized controlled trials assessing cognitive, motor, and behavioral domains. Results: A total of 22 studies met the inclusion criteria, comprising 18 observational studies (81.8%) and 4 randomized controlled trials (18.2%). Vitamin D was the most frequently investigated micronutrient, followed by vitamin B12 and folate-related exposures. Adequate maternal vitamin B12 status was consistently associated with improved language, memory, and cognitive performance, while vitamin D deficiency during pregnancy was linked to poorer motor and neurocognitive outcomes. Folic acid supplementation, particularly when initiated in the periconceptional period, demonstrated the most consistent favorable associations extending beyond neural tube defect prevention, including improved cognitive and language development. However, substantial methodological heterogeneity limited quantitative synthesis. Conclusion: Maternal vitamin B12, vitamin D, and folate status appear to play an important role in shaping early neurodevelopment. In the context of increasing consumption of ultra-processed foods and declining micronutrient density in modern diets, these findings underscore the need for strengthened nutritional surveillance, targeted supplementation strategies, and updated public health policies to support optimal neurodevelopmental outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.